BIM
DMTX

BlackRock Investment Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

BlackRock Investment Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$203K Hold
46,714
– – ﹤0.01% 3228
2016
Q3 		$373K Sell
46,714
-136
-0.3% -$983 ﹤0.01% 3137
2016
Q2 		$281K Buy
46,850
+30,075
+179% +$229K ﹤0.01% 3236
2016
Q1 		$131K Buy
16,775
+8,039
+92% +$63.3K ﹤0.01% 3215
2015
Q4 		$99K Buy
+8,736
New +$111K ﹤0.01% 3277

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

BlackRock Investment Management's DMTX Position: Q4 2016 in Review

BlackRock Investment Management held its Dimension Therapeutics, Inc (DMTX) position steady in Q4 2016 at 46,714 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

BlackRock Investment Management first reported a position in DMTX in Q4 2015 and has held it in 5 quarters since. The position peaked at $373K in Q3 2016. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

  • BlackRock Investment Management held 46,714 shares of Dimension Therapeutics, Inc worth $203K as of Q4 2016.
  • BlackRock Investment Management left its Dimension Therapeutics, Inc share count unchanged in Q4 2016.
  • Dimension Therapeutics, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3228 holding.
  • BlackRock Investment Management first reported a position in Dimension Therapeutics, Inc in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Investment Management's Dimension Therapeutics, Inc position peaked at $373K in Q3 2016.
  • 55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.